Update shared on 14 Dec 2025
Fair value Increased 3.58%Analysts have raised their price target on Rocket Companies from approximately 24.13 dollars to 25.00 dollars, citing expectations for significantly faster revenue growth despite projecting somewhat lower long term profit margins and a slightly higher discount rate.
Valuation Changes
- Fair Value Estimate has risen slightly from approximately $24.13 to $25.00 per share.
- Discount Rate has increased modestly from about 7.77 percent to roughly 8.16 percent, reflecting a marginally higher perceived risk profile.
- Revenue Growth has risen significantly, moving from an estimated 21.88 percent to about 41.56 percent, indicating much stronger top line expectations.
- Net Profit Margin has fallen meaningfully from roughly 43.54 percent to about 33.18 percent, suggesting lower long term profitability assumptions.
- Future P/E has edged down slightly from around 19.18 times earnings to approximately 19.01 times, implying a marginally lower valuation multiple.
Have other thoughts on Rocket Companies?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.